SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 30, 2003
Commission File Number: 000-49620
Biogentech Corporation
----------------------
(Exact name of registrant as specified in its charter)
Nevada 91-1868007
------ ----------
(State or other jurisdiction of (I.R.S. Employer Identification No.)
incorporation or organization)
2445 McCabe Way, Suite 150, Irvine, California 92614
---------------------------------------------------- -----
(Address of principal executive offices) (Zip Code)
(949) 757-0001
--------------
(Registrant's Telephone Number, Including Area Code)
------------------
(Former name or former address, if changed since last report)
1
ITEM 5. OTHER EVENTS AND REGULATION FD DISCLOSURE
Reference is made to the Biogentech Corporation's (the "Registrant")
press release dated July 31, 2003, furnished herewith as Exhibit 99.1 and is
incorporated herein by reference.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS.
(a) Not applicable.
(b) Not applicable.
(c) Exhibits
99.1 Press Release of Registrant, dated July 31, 2003, reporting the
Registrant's definitive agreement with InnoFood, Inc.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
Biogentech Corporation
July 30, 2003 By: /s/ Chaslov Radovich
-----------------------------------
Chaslov Radovich, President
EXHIBIT INDEX
EXHIBIT DESCRIPTION OF EXHIBIT
NUMBER
99.1 Press Release of Registrant, dated July 31, 2003, reporting the
Registrant's definitive agreement with InnoFood, Inc.
3